Key Points
-
Yeast has proven a valuable model system to understand eukaryotic transcription mechanisms. Extending the vale of the system even further, several investigators have attempted to express mammalian transcriptional activators or repressors directly in yeast.
-
Mammalian transcriptional activators have been tested in yeast either directly or as fusion proteins targeted to reporters by fusion to a yeast DNA-binding domain. Most mammalian activators retain function in yeast.
-
Yeast is an ideal system to carry out structure–function analysis. In many cases, activation domains of mammalian activators have been defined in yeast. Fine-structure analysis has also been carried out, particularly with p53. Several screens have identified point mutations in p53 that alter its activation potential.
-
When a mammalian activator is expressed in yeast and studied at a reporter where its endogenous DNA-binding sites have been inserted, structure–function analysis has been carried out both to map DNA-binding regions within the activator and to identify the ideal DNA-binding sequence.
-
Genetic approaches have been used in yeast to identify potential co-activators for mammalian transcription factors. This has been particularly useful in the case of nuclear hormone receptors, in which both the yeast SAGA–ADA and the SWI–SNF complex among other proteins have been identified as important for activator function.
-
Nuclear hormone receptors require binding to hormone for full activation potential. This hormone-dependent stimulation can be recapitulated in yeast, which has led investigators to map hormone-binding domains and study the efficacy of different ligands. Furthermore, regulation of activator function in yeast by phosphorylation and binding to other mammalian regulatory proteins has been studied.
-
Transcriptional repression by mammalian proteins has also been shown in yeast, although to a lesser extent than with activators. Both Mad–Max and pRB recruit histone deacetylase activity in yeast much as they do in mammalian cells.
Abstract
Many transcription factors in human cells have functional orthologues in yeast, and a common experimental theme has been to define the function of the yeast protein and then test whether the mammalian version behaves similarly. Although, at first glance, this approach does not seem feasible for factors that do not have yeast counterparts, mammalian transcriptional activators or repressors can be expressed directly in yeast. Often, the mammalian factor retains function in yeast, and this allows investigators to exploit the experimental tractability of yeast to ask a diverse set of questions.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout






Similar content being viewed by others
References
Brownell, J. et al. Tetrahymena histone acetyltransferase A: a homolog to yeast Gcn5p linking histone acteylation to gene expression. Cell 84, 843–851 (1996).
Taunton, J., Hassig, C. A. & Schreiber, S. L. A mammalian histone deacetylase related to the yeast transcriptional regulator Rpd3p. Science 272, 408–411 (1996).
Chen, D. et al. Regulation of transcription by a protein methyltransferase. Science 284, 2174–2177 (1999).
Strahl, B. D., Ohba, R., Cook, R. G. & Allis, C. D. Methylation of histone H3 at lysine 4 is highly conserved and correlates with transcriptionally active nuclei in Tetrahymena. Proc. Natl Acad. Sci. USA 96, 14967–14972 (1999).
Rea, S. et al. Regulation of chromatin structure by site-specific histone H3 methyltransferases. Nature 406, 593–599 (2000).
Sassone-Corsi, P et al. Requirement of Rsk-2 for epidermal growth factor-activated phosphorylation of histone H3. Science 285, 886–891 (1999).
Thomson, S. et al. The nucleosomal response associated with immediate-early gene induction is mediated via alternative MAP kinase cascades: MSK1 as a potential histone H3/HMG-14 kinase. EMBO J. 18, 4779–4793 (1999).
Bestor, T., Laudano, A., Mattaliano, R. & Ingram, V. Cloning and sequencing of a cDNA methyltransferase of mouse cells. The carboxy-terminal domain of the mammalian enzymes is related to bacterial restriction methyltransferases. J. Mol. Biol. 203, 971–983 (1988).
Okano, M., Xie, S. & Li, E. Cloning and characterization of a family of novel mammalian DNA (cytosine-5) methyltransferases. Nature Genet. 19, 219–220 (1998).
Kawasaki, H. et al. ATF-2 has intrinsic histone acetyltransferase activity which is modulated by phosphorylation. Nature 405, 195–200 (2000).
Laurent, B. C., Treich, I. & Carlson, M. The yeast SNF2/SWI2 protein has DNA-stimulated ATPase activity required for transcriptional activation. Genes Dev. 7, 583–591 (1993).
Cote, J., Quinn, J., Workman, J. L. & Peterson, C. L. Stimulation of GAL4 derivative binding to nucleosomal DNA by the yeast SWI/SNF complex. Science 265, 53–60 (1994).
Kwon, H., Imbalzano, A. N., Khavari, P. A., Kingston, R. E. & Green, M. R. Nucleosome disruption and enhancement of activator binding by a human SWI/SNF complex. Nature 370, 477–481 (1994).
Näär, A. M., Lemon, B. D. & Tjian, R. Transcriptional coactivator complexes. Annu. Rev. Biochem. 70, 475–501 (2001).
Strubin, M. & Struhl, K. Yeast and human TFIID with altered DNA-binding specificity for TATA elements. Cell 68, 721–730 (1992).
Keaveney, M., Berkenstam, A., Feigenbutz, M., Vriend, G. & Stunnenberg, H. G. Residues in the TATA-binding protein required to mediate a transcriptional response to retinoic acid in EC cells. Nature 365, 562–566 (1993).
Cormack, B. P., Strubin, M., Stargell, L. A. & Struhl, K. Conserved and nonconserved functions of the yeast and human TATA-binding proteins. Genes Dev. 8, 1335–1343 (1994).
Sweetser, D., Nonet, M. & Young, R. Prokaryotic and eukaryotic RNA polymerases have homologous core subunits. Proc. Natl Acad. Sci. USA 84, 1192–1196 (1987).
Dynlacht, B. D., Hoey, T. & Tjian, R. Isolation of coactivators associated with the TATA-binding protein that mediate transcriptional activation. Cell 66, 563–576 (1991).
Candau, R. et al. Identification of human proteins functionally conserved with the yeast putative adaptors ADA2 and GCN5. Mol. Cell. Biol. 16, 593–602 (1996).
Yang, X. J., Ogryzko, V. V., Nishikawa, J., Howard, B. H. & Nakatani, Y. A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A. Nature 382, 319–324 (1996).
Khavari, P. A., Peterson, C. L., Tamkun, J. W., Mendel, D. B. & Crabtree, G. R. BRG1 contains a conserved domain of the SWI2/SNF2 family necessary for normal mitotic growth and transcription. Nature 366, 170–174 (1993).
Brent, R. & Ptashne, M. A eukaryotic transcriptional activator bearing the DNA specificity of a prokaryotic repressor. Cell 43, 729–736 (1985).
Hope, I. A. & Struhl, K. Functional dissection of a eukaryotic transcriptional activator protein, GCN4 of yeast. Cell 46, 885–894 (1986).
Fields, S. & Song, O. A novel genetic system to detect protein–protein interactions. Nature 340, 245–246 (1989).
Struhl, K. The DNA-binding domains of the jun oncoprotein and the yeast GCN4 transcriptional activator protein are functionally homologous. Cell 50, 841–846 (1987).
Bohmann, D. et al. Human proto-oncogene c-jun encodes a DNA binding protein with structural and functional properties of transcription factor AP-1. Science 238, 1386–1392 (1987).
Kakidani, H. & Ptashne, M. GAL4 activates gene expression in mammalian cells. Cell 52, 161–167 (1988).
Webster, N., Jin, J. R., Green, S., Hollis, M. & Chambon, P. The yeast UASG is a transcriptional enhancer in human HeLa cells in the presence of the GAL4 trans-activator. Cell 52, 169–178 (1988).References 28 and 29 were the first reports to show that yeast activators can function in mammalian cells.
Struhl, K. The JUN oncoprotein, a vertebrate transcription factor, activates transcription in yeast. Nature 332, 649–650 (1988).
Lech, K., Anderson, K. & Brent, R. DNA-bound Fos proteins activate transcription in yeast. Cell 52, 179–184 (1988).References 30 and 31 show that mammalian activators can function in yeast.
McEwan, I. J. Bakers yeast rises to the challenge: reconstitution of mammalian steroid receptor signaling in S. cerevisiae. Trends Genet. 17, 239–243 (2001).
Metzger, D., White, J. H. & Chambon, P. The human oestrogen receptor functions in yeast. Nature 334, 31–36 (1988).
Schena, M. & Yamamoto, K. R. Mammalian glucocorticoid receptor derivatives enhance transcription in yeast. Science 241, 965–967 (1988).References 33 and 34 were the first to show that nuclear steroid hormone receptors activate transcription in yeast.
Kunzler, M., Braus, G. H., Georgiev, O., Seipel, K. & Schaffner, W. Functional differences between mammalian transcription activation domains at the yeast GAL1 promoter. EMBO J. 13, 641–645 (1994).
Kim, T. K. & Roeder, R. G. Transcriptional activation in yeast by the proline-rich activation domain of human CTF1. J. Biol. Chem. 268, 20866–20869 (1993).
Ponticelli, A. S., Pardee, T. S. & Struhl, K. The glutamine-rich activation domains of human Sp1 do not stimulate transcription in Saccharomyces cerevisiae. Mol. Cell. Biol. 15, 983–988 (1995).
Prakash, K., Fang, X. D., Engelberg, D., Behal, A. & Parker, C. S. dOct2, a Drosophila Oct transcription factor that functions in yeast. Proc. Natl Acad. Sci. USA 89, 7080–7084 (1992).
Xiao, H. & Jeang, K. T. Glutamine-rich domains activate transcription in yeast Saccharomyces cerevisiae. J. Biol. Chem. 273, 22873–22876 (1998).
Escher, D., Bodmer-Glavas, M., Barberis, S. & Schaffner, W. Conservation of glutamine-rich transactivation function between yeast and humans. Mol. Cell. Biol. 20, 2774–2782 (2000).Interesting study that shows that re-establishing a mammalian promoter structure in yeast might be important for a corresponding mammalian activator to function in yeast.
Giese, K., Cox, J. & Grosschedl, R. The HMG domain of lymphoid enhancer factor 1 bends DNA and facilitates assembly of functional nucleoprotein structures. Cell 69, 185–195 (1992).
Paull, T. T., Haykinson, M. J. & Johnson, R. C. The nonspecific DNA-binding and -bending proteins HMG1 and HMG2 promote the assembly of complex nucleoprotein structures. Genes Dev. 7, 1521–1534 (1992).
Landsman, D. & Bustin, M. Assessment of the transcriptional activation potential of the HMG chromosomal proteins. Mol. Cell. Biol. 11, 4483–4489 (1991).
Ma, J. & Ptashne, M. A new class of yeast transcriptional activators. Cell 51, 113–119 (1987).
Morin, P. J. & Gilmore, T. D. The C terminus of the NF-κB p50 precursor and an IκB isoform contain transcription activation domains. Nucleic Acids Res. 20, 2453–2458 (1992).
Pham, T. A., Hwung, Y.-P., Santiso-Mere, D., McDonnell, D. P. & O' Malley, B. W. Ligand-dependent and -independent function of the transactivation regions of the human estrogen receptor in yeast. Mol. Endocrinol. 6, 1043–1050 (1992).
Chen, R. H. & Lipsick, J. S. Differential transcriptional activation by v-myb and c-myb in animal cells and Saccharomyces cerevisiae. Mol. Cell. Biol. 13, 4423–4431 (1993).
Seneca, S. et al. The carboxy-terminal domain of c-Myb activates reporter gene expression in yeast. Oncogene 8, 2335–2342 (1993).
Xie, K., Lambie, E. J. & Snyder, M. Nuclear dot antigens may specify transcriptional domains in the nucleus. Mol. Cell. Biol. 13, 6170–6179 (1993).
Monaci, P. et al. A complex interplay of positive and negative elements is responsible for the different transcriptional activity of liver NF1 variants. Mol. Biol. Rep. 21, 147–158 (1995).
Yamaguchi, Y. & Kuo, M. T. Functional analysis of aryl hydrocarbon receptor nuclear translocator interactions with aryl hydrocarbon receptor in the yeast two-hybrid system. Biochem. Pharmacol. 50, 1295–1302 (1995).
Monteiro, A. N. A., August, A. & Hanafusa, H. Evidence for a transcriptional activation function of BRCA1 C-terminal region. Proc. Natl Acad. Sci. USA 93, 13595–13599 (1996).
Rowlands, J. C., McEwan, I. J. & Gustafsson, J.-Å. Trans-activation by the human aryl hydrocarbon receptor and aryl hydrocarbon receptor nuclear translocator proteins: direct interactions with basal transcription factors. Mol. Pharmocol. 50, 538–548 (1996).
Hecht, A., Letterst, C. M., Huber, O. & Kemier, R. Functional characterization of multiple transactivating elements in β-catenin, some of which interact with the TATA-binding protein in vitro. J. Biol. Chem. 274, 18017–18025 (1999).
Almlöf, T., Gustafsson, J.-Å. & Wright, A. P. H. Role of hydrophobic amino acid clusters in the transactivation activity of the human glucocorticoid receptor. Mol. Cell. Biol. 17, 934–945 (1997).
Fields, S. & Jang, S. K. Presence of a potent transcription activating sequence in the p53 protein. Science 249, 1046–1049 (1990).
Shimada, A. et al. The transcriptional activities of p53 and its homologue p51/p63: similarities and differences. Cancer Res. 59, 2781–2789 (1999).
Nozaki, M. et al. p73 is not mutated in meningiomas as determined with a functional yeast assay but p73 expression increases with tumor grade. Brain Pathol. 11, 296–305 (2001).
Scharer, E. & Iggo, R. Mammalian p53 can function as a transcription factor in yeast. Nucleic Acids Res. 20, 1539–1545 (1992).This paper shows that tumour-derived p53 mutants fail to activate transcription in yeast.
Di Como, C. J. & Prives, C. Human tumor-derived p53 proteins exhibit binding site selectivity and temperature sensitivity for transactivation in a yeast-based assay. Oncogene 16, 2527–2539 (1998).
Flaman, J. M. et al. Identification of human p53 mutations with differential effects on the bax and p21 promoters using functional assays in yeast. Oncogene 16, 1369–1372 (1998).
Campomenosi, P. et al. p53 mutants can often transactivate promoters containing a p21 but not Bax or PIG3 responsive elements. Oncogene 20, 3573–3579 (2001).
Epstein, C. B. et al. p53 mutations isolated in yeast based on loss of transcription factor activity: similarities and differences from p53 mutations detected in human tumors. Oncogene 16, 2115–2122 (1998).
Ishioka, C. et al. Screening patients for heterozygous p53 mutations using a functional assay in yeast. Nature Genet. 5, 124–129 (1993).
Meinhold-Heerlein, I. et al. Evaluation of methods to detect p53 mutations in ovarian cancer. Oncology 60, 176–188 (2001).
Inga, A. et al. Simple identification of dominant p53 mutants by a yeast functional assay. Carcinogenesis 18, 2019–2021 (1997).
Inga, A., Monti, P., Fronza, G., Darden, T. & Resnick, M. A. p53 mutants exhibiting enhanced transcriptional activation and altered promoter selectivity are revealed using a sensitive, yeast-based functional assay. Oncogene 20, 501–513 (2001).
Brachmann, R. K., Yu, K., Eby, Y., Pavletich, N. P. & Boeke, J. D. Genetic selection of intragenic suppressor mutations that reverse the effect of common p53 cancer mutations. EMBO J. 17, 1847–1859 (1998).Isolation of second-site intragenic mutations which restore transactivation to tumour-derived TP53 mutants — a possible framework for small-molecule design.
Maurici, D. et al. Amifostine (WR2721) restores transcriptional activity of specific p53 mutant proteins in a yeast functional assay. Oncogene 20, 3533–3540 (2001).
Nigro, J. M., Sikorski, R., Reed, S. I. & Vogelstein, B. Human p53 and CDC2Hs genes combine to inhibit the proliferation of Saccharomyces cerevisiae. Mol. Cell. Biol. 12, 1357–1365 (1992).
Inga, A. & Resnick, M. A. Novel human p53 mutations that are toxic to yeast can enhance transactivation of specific promoters and reactivate tumor p53 mutants. Oncogene 20, 3409–3419 (2001).
Olson, D. P. & Koenig, R. J. 5′-flanking sequences in thyroid hormone response element half-sites determine the requirement of retinoid X receptor for receptor-mediated gene expression. J. Biol. Chem. 272, 9907–9914 (1997).
Brent, G. A. et al. Mutations of the rat growth hormone promoter which increase and decrease response to thyroid hormone define a consensus thyroid hormone response element. Mol. Endocrinol. 3, 1996–2004 (1989).
Katz, R. W. & Koenig, R. J. Nonbiased identification of DNA sequences that bind thyroid hormone receptor α1 with high affinity. J. Biol. Chem. 268, 19392–19397 (1993).
Berge, T., Bergholtz, S. L., Andersson, K. B. & Gabrielson, O. S. A novel system for in vivo selection of recognition sequences: defining an optimal c-Myb-responsive element. Nucleic Acids Res. 29, E99 (2001).This report describes a system to identify optimal mammalian transcription-factor-binding sites in yeast.
Henry, K. W., Carey, B., Howard, W. R., Hoefner, D. & Noonan, D. J. Use of Saccharomyces cerevisiae in the identification of novel transcription factor DNA binding specificities. Yeast 18, 445–454 (2001).
Yoshinaga, S. K., Peterson, C. L., Herskowitz, I. & Yamamoto, K. R. Roles of SWI1, SWI2, and SWI3 proteins for transcriptional enhancement by steroid receptors. Science 258, 1598–1604 (1992).This study shows that glucocorticoid-receptor-dependent activation requires the SWI–SNF complex.
Cairns, B. R., Levinson, R. S., Yamamoto, K. R. & Kornberg, R. D. Essential role of Swp73p in the function of yeast Swi/Snf complex. Genes Dev. 10, 2131–2144 (1996).
Gilbert, D. M., Losson, R. & Chambon, P. Ligand dependence of estrogen receptor induced changes in chromatin structure. Nucleic Acids Res. 20, 4525–4531 (1992).
Henrikksson, A. et al. Role for the Ada adaptor complex in gene activation by the glucocorticoid receptor. Mol. Cell. Biol. 17, 3065–3073 (1997).This paper shows that glucocorticoid-receptor-dependent activation requires the SAGA–ADA complex.
Wallberg, A. E. et al. Recruitment of the SWI-SNF chromatin remodeling complex as a mechanism of gene activation by the glucocorticoid receptor τ1 activation domain. Mol. Cell. Biol. 20, 2004–2013 (2000).
Anafi, M. et al. GCN5 and ADA adaptor proteins regulate triiodothyronine/GRIP1 and SRC-1 coactivator-dependent gene activation by the human thyroid hormone receptor. Mol. Endocrinol. 14, 718–732 (2000).
Vom Baur, E. et al. The yeast Ada complex mediates the ligand-dependent activation function AF-2 of retinoid X and estrogen receptors. Genes Dev. 12, 1278–1289 (1998).
Bortvin, A. & Winston, F. Evidence that Spt6p controls chromatin structure by a direct interaction with histones. Science 272, 1473–1476 (1996).
Hartzog, G. A., Wada, T., Handa, H. & Winston, F. Evidence that Spt4, Spt5, and Spt6 control transcription elongation by RNA polymerase II in Saccharomyces cerevisiae. Genes Dev. 12, 357–369 (1998).
Wada, T. et al. DSIF, a novel transcription elongation factor that regulates RNA polymerase II processivity, is composed of human Spt4 and Spt5 homologs. Genes Dev. 12, 343–356 (1998).
Baniahmad, C. et al. Enhancement of human estrogen receptor activity by SPT6: a potential coactivator. Mol. Endocrinol. 9, 34–43 (1995).
Knutti, D., Kaul, A. & Kralli, A. A tissue-specific coactivator of steroid receptors, identified in a functional genetic screen. Mol. Cell. Biol. 20, 2411–2422 (2000).The authors carry out a screen, which identifies PGC-1 as a complementary DNA that potentiates glucocorticoid-receptor function in yeast.
Puigserver, P. et al. A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis. Cell 92, 829–839 (1998).
Puigserver, P. et al. Activation of PPARγ coactivator-1 through transcription factor docking. Science 286, 1368–1371 (1999).
Monsalve, M. et al. Direct coupling of transcription and mRNA processing through the thermogenic coactivator PGC-1. Mol. Cell 6, 307–316 (2000).
Garabedian, M. J. & Yamamoto, K. R. Genetic dissection of the signaling domain of a mammalian steroid receptor in yeast. Mol. Biol. Cell 3, 1245–1257 (1992).This report uses yeast to analyse the hormone-binding domain of the glucocorticoid receptor.
Wrenn, C. K. & Katzenellenbogan, B. S. Structure–function analysis of the hormone binding domain of the estrogen receptor by region-specific mutagenesis and phenotypic screening in yeast. J. Biol. Chem. 268, 24089–24098 (1993).
Lind, U., Carlstedt-Duke, J., Gustafsson, J.-Å. & Wright A. P. H. Identification of single amino acid substitutions of Cys-736 that affect the steroid-binding affinity and specificity of the glucocorticoid receptor using phenotypic screening in yeast. Mol. Endocrinol. 10, 1358–1370 (1996).
Kralli, A., Bohen, S. P. & Yamamoto, K. R. LEM1, an ATP-binding-cassette transporter, selectively modulates the biological potency of steroid hormones. Proc. Natl Acad. Sci. USA 92, 4701–4705 (1995).
Gilbert, D. M., Heery, D. M., Losson, R., Chambon, P. & Lemoine, Y. Estradiol-inducible squelching and cell growth arrest by a chimeric VP16-estrogen receptor expressed in Saccharomyces cerevisiae: suppression by an allele of PDR1. Mol. Cell. Biol. 13, 462–472 (1993).
Sitcheran, R., Emter, R., Kralli, A. & Yamamoto, K. R. A genetic analysis of glucocorticoid receptor signaling: identification and characterization of ligand-effect modulators in Saccharomyces cerevisiae. Genetics 156, 963–972 (2000).
Housley, P. R. & Pratt, W. B. Direct demonstration of glucocorticoid receptor phosphorylation by intact L-cells. J. Biol. Chem. 258, 4630–4635 (1983).
Orti, E., Mendel, D. B., Smith, L. I. & Munck, A. Agonist dependent phosphorylation and nuclear dephosphorylation of glucocorticoid receptors in intact cells. J. Biol. Chem. 264, 9728–9731 (1989).
Hoeck, W. & Groner, B. Hormone-dependent phosphorylation of the glucocorticoid receptor occurs mainly in the amino-terminal transactivation domain. J. Biol. Chem. 265, 5403–5408 (1990).
Pocuca, N., Ruzdijic, S., Demonacos, C., Kanazir, D. & Krstic-Demonacos, M. Using yeast to study glucocorticoid receptor phosphorylation. J. Steroid Biochem. 66, 303–318 (1998).
Krstic, M. D., Rogatsky, I., Yamamoto, K. R. & Garabedian, M. J. Mitogen-activated and cyclin-dependent protein kinases selectively and differentially modulate transcriptional enhancement by the glucocorticoid receptor. Mol. Cell. Biol. 17, 3947–3954 (1997).
Epinat, J.-C., Whiteside, S. T., Rice, N. R. & Israel, A. Reconstitution of the NF-κ>B system in Saccharomyces cerevisiae for isolation of effectors by phenotype modulation. Yeast 13, 599–612 (1997).
Ayer, D. E., Kertzmer, L. & Eisenman, R. N. Mad: a heterodimeric partner for Max that antagonizes Myc transcriptional activity. Cell 72, 211–222 (1993).
Kasten, M. M., Ayer, D. E. & Stillman, D. J. SIN3-dependent transcriptional repression by interaction with the Mad1 DNA-binding protein. Mol. Cell. Biol. 16, 4215–4221 (1996).This, to my knowledge, is the first report showing that mammalian repressors function in yeast.
Ayer, D. E., Lawrence, Q. A. & Eisenman, R. N. Mad–Max transcriptional repression is mediated by ternary complex formation with mammalian homologs of yeast repressor Sin3. Cell 80, 767–776 (1995).
Weintraub, S. J., Prater, C. J. & Dean, D. C. Retinoblastoma protein switches the E2F site from positive to negative element. Nature 358, 259–261 (1992).
Laherty, C. D. et al. Histone deacetylases associated with the mSin3 corepressor mediate Mad transcriptional repression. Cell 89, 349–356 (1997).
Kennedy, B. K. et al. Histone deacetylase-dependent transcriptional repression by pRB in yeast occurs independently of interaction through the LXCXE binding cleft. Proc. Natl Acad. Sci. USA 98, 8720–8725 (2001).
Brehm, A. et al. Retinoblastoma protein recruits histone deacetylase to repress transcription. Nature 391, 597–601 (1998).
Luo, R. X., Postigo, A. A. & Dean, D. C. Rb interacts with histone deacetylase to repress transcription. Cell 92, 463–473 (1998).
Magnaghi-Jaulin, L. et al. Retinoblastoma protein represses transcription by recruiting a histone deacetylase. Nature 391, 601–605 (1998).
Chen, T.-T. & Wang, J. Y. J. Establishment of irreversible growth arrest in myogenic differentiation requires the RB LXCXE-binding function. Mol. Cell. Biol. 20, 5571–5580 (2000).
Dahiya, A., Gavin, M. R., Luo, R. X. & Dean, D. C. Role of the LXCXE binding site in Rb function. Mol. Cell. Biol. 20, 6799–6805 (2000).
Dick, F. A., Sailhamer, E. & Dyson, N. Mutagenesis of the pRB pocket reveals that cell cycle arrest functions are separable from binding to viral oncoproteins. Mol. Cell. Biol. 20, 3715–3727 (2000).
Acknowledgements
The author would like to thank A. Weiner for comments on the manuscript, and would also like to apologize for any reports that were not cited in the manuscript.
Author information
Authors and Affiliations
Glossary
- BASAL TRANSCRIPTION FACTORS
-
The minimal complement of proteins that is necessary to generate transcription from a minimal promoter.
- HATs
-
Enzymes that have histone acetyltransferase activity. They are generally thought to stimulate transcription.
- HDACs
-
Enzymes that deacetylate histones. They are generally thought to promote repressive chromatin states.
- HISTONE METHYLASE
-
Enzyme that transfers methyl groups to histone tails.
- HISTONE KINASE
-
Enzyme that phosphorylates histones.
- TATA BOX
-
A DNA-binding site for the formation of transcription pre-initiation complexes that contain RNA polymerase.
- ORTHOLOGUE
-
A pair of genes, one in each species, that are descended from a single gene. If these two genes encode proteins with functional similarity, they are referred to as functional orthologues.
- ENHANCER ELEMENT
-
(Also known as upstream activating sequence (UAS) elements in yeast.) Upstream DNA-binding sequences for transcriptional activators.
- HETEROLOGOUS
-
For this review, heterologous refers to mammalian proteins that are expressed in yeast, but do not have functional orthologues in yeast.
- SECOND-SITE INTRAGENIC SUPPRESSOR
-
A second mutation in a gene that reverses the effect of the original mutation.
- PHENOCOPY
-
An environmental or non-hereditary change that resembles the phenotype of a genetic mutation.
- SWI/SNF
-
An ATP-dependent chromatin- modifying protein complex that is required for expression of many genes. This complex has also been implicated in transcriptional repression of other genes.
- SAGA/ADA
-
A protein complex that includes Ada proteins, the TATA-binding protein (TBP) set of Spt gene products, and some TATA-box-associated factors (TAFs). This complex promotes transcriptional activation, at least in part, through histone acetyltransferase activity.
- ATP-BINDING CASSETTE PROTEIN
-
From a large class of transport proteins that move molecules across membranes in an ATP-dependent manner.
- DEXAMETHASONE
-
A potent glucocorticoid with immunosuppressant effects that potently stimulates the activity of some nuclear hormone receptors, including the glucocorticoid receptor.
- NF-κB/IκB
-
NF-κB is a transcription factor that activates genes that are involved in cell growth, as well as immune and inflammatory responses. IκB is thought to interfere with NF-κB activity at least in part by sequestering it in the cytoplasm.
Rights and permissions
About this article
Cite this article
Kennedy, B. Mammalian transcription factors in yeast: strangers in a familiar land. Nat Rev Mol Cell Biol 3, 41–49 (2002). https://doi.org/10.1038/nrm704
Issue date:
DOI: https://doi.org/10.1038/nrm704
This article is cited by
-
Directed evolution in mammalian cells
Nature Methods (2021)
-
Systematic discovery of novel eukaryotic transcriptional regulators using sequence homology independent prediction
BMC Genomics (2017)
-
The tumor suppressor p53 associates with gene coding regions and co-traverses with elongating RNA polymerase II in an in vivo model
Oncogene (2008)


